Biden team held COVID-19 talks with Operation Warp Speed drugmakers before election

(Reuters) - U.S. President-elect Joe Biden's healthcare advisers have held talks with drugmaker executives on the U.S. government's Operation Warp Speed program to accelerate development of a possible COVID-19 treatment, a Biden spokesman said on Sunday

Reuters November 09, 2020 07:10:17 IST
Biden team held COVID-19 talks with Operation Warp Speed drugmakers before election

COVID-19 talks with Operation Warp Speed drugmakers before election" src="https://images.firstpost.com/wp-content/uploads/reuters/11-2020/09/2020-11-09T011620Z_1_LYNXMPEGA8019_RTROPTP_2_HEALTH-CORONAVIRUS-USA-VACCINE-BIDEN.jpg" alt="Biden team held COVID19 talks with Operation Warp Speed drugmakers before election" width="300" height="225" />

(Reuters) - U.S. President-elect Joe Biden's healthcare advisers have held talks with drugmaker executives on the U.S. government's Operation Warp Speed program to accelerate development of a possible COVID-19 treatment, a Biden spokesman said on Sunday.

Under the Trump administration, Operation Warp Speed has struck deals with several drugmakers in an effort to help speed up the search for effective treatments for the disease amid the global coronavirus pandemic.

The U.S. COVID-19 death toll stands at over 237,000, with more than 9.9 million cases now reported in the country since the outbreak began, according to a Reuters tally.

"As we previously said in September, because President-Elect Joe Biden is absolutely committed to helping develop a safe and effective coronavirus vaccine as soon as possible, campaign medical advisers have received briefings from companies working to produce vaccines in order to be informed about the process," Biden's spokesman Andrew Bates said in an emailed statement.

Biden's advisers met with companies that have COVID-19 vaccines or therapies in late-stage clinical trials in September and October, Bloomberg News had reported earlier.

The report added that the meeting was aimed at gathering information about the development, manufacturing and distribution of shots to ward off the novel coronavirus and therapies to treat the sick.

Biden has vowed to "listen to the science", with his coronavirus plan calling for scaling up testing and contact tracing and promising to appoint a "supply commander" to oversee supply lines of critical equipment.

Late in October, Health and Human Services Secretary Alex Azar said the United States is likely to have enough safe and effective COVID-19 vaccines available to inoculate the most vulnerable Americans by the end of 2020.

In their talks, Biden's advisers indicated to drug company officials that his administration would not be interested in making changes to Warp Speed that would disrupt work in getting new drugs and vaccines to market, Bloomberg reported, adding his administration will want to assist the companies' efforts when Biden assumes office.

The coronavirus outbreak has been worsening in recent weeks as cold weather pushes Americans indoors, raising the chance of contracting the virus.

(Reporting by Trevor Hunnicutt in Wilmington, Delaware and Kanishka Singh in Bengaluru; Editing by Kenneth Maxwell)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

U.S. data suggest economic recovery may be weakening
Business

U.S. data suggest economic recovery may be weakening

By Howard Schneider WASHINGTON (Reuters) - The explosive surge in U.S. coronavirus cases this fall has left a question hanging: When will the economy take its own turn for the worse

Fed, ECB heads give COVID-19 vaccine cautious welcome
Business

Fed, ECB heads give COVID-19 vaccine cautious welcome

FRANKFURT/WASHINGTON (Reuters) - The heads of the Federal Reserve and the European Central Bank welcomed the encouraging results in trials of a vaccine candidate for the novel coronavirus but stressed that the economic outlook will remain uncertain. Fed chair Jay Powell and ECB President Christine Lagarde said the economy was still in for a tough time even if the development of a potential vaccine by U.S. drugmaker Pfizer and German partner BioNTech SE was reason for some optimism further ahead

India's October fuel demand marks first year-on-year gain in 8 months
Business

India's October fuel demand marks first year-on-year gain in 8 months

By Sumita Layek (Reuters) - India's fuel consumption in October registered its first year-on-year increase since February, as slowing coronavirus cases and increased mobility accelerated an economic recovery, data showed on Thursday.